Mimedx MDXG
NASDAQ MDXG
$4.51 -0.16 (-3.53%)
As of: Sep 10, 2026 · 12:40 PM EDT

Mimedx (MDXG) Long-Term Investments (2014 - 2015)

Mimedx's (MDXG) quarterly Long-Term Investments came in at $2.5 million in Q1 2015, down 23.08% quarter-over-quarter from $3.2 million in Q4 2014.

Analysis

Mimedx (MDXG) Long-Term Investments (2014 - 2015) Analysis & Trends

Mimedx has disclosed Long-Term Investments across 2 years of filings, most recently posting $2.5 million for Q1 2015.

  • In Q1 2015, Long-Term Investments changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2015 stood at $2.5 million (changed N/A YoY), while the FY2014 annual figure was $3.2 million, changed N/A from the prior year.
  • Long-Term Investments came in at $2.5 million for Q1 2015 at Mimedx, down from $3.2 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $3.2 million in Q4 2014 to a low of $2.5 million in Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn 1.11 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn 3.41 Bn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn -
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn -
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn 2.25 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 244.10 Mn
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn -
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn -
10 Mimedx 667.30 Mn 531.46 Mn 44.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 2.50 Mn
Dec 31, 2014 3.25 Mn